Rationally Designed Ru(II) Complex with Dual Type I/II ROS Generation for Hypoxia-Tolerant Photodynamic Therapy in Melanoma
Inorganic Chemistry · 2026
DOI: 10.1021/acs.inorgchem.6c04054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2026. Verfasst von Xueling Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Molecular Sciences, Henan University, Kaifeng475004, P. R. China. Hauptthemen laut MEDLINE: Photochemotherapy, Ruthenium, Reactive Oxygen Species, Coordination Complexes. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Henan Provincial Science and Technology Research Project.
Abstract (Originalsprache)
The hypoxic tumor microenvironment of melanoma imposes a critical limitation on conventional type II photodynamic therapy (PDT), relying on oxygen for the generation of cytotoxic reactive oxygen species (ROS). To overcome this challenge, a donor-π-acceptor (D-π-A) bis-terpyridine ruthenium(II) complex, Ru(tpy)2TT, was rationally designed and synthesized to enable dual type I/II ROS generation. The ROS production efficiency was quantitatively evaluated in B16 murine melanoma cells, and the antitumor efficacy was assessed in a syngeneic C57BL/6N mouse melanoma model. Upon photoactivation at 500 nm, Ru(tpy)2TT efficiently generated both superoxide anion (type I ROS) and singlet oxygen (type II ROS). Intratumoral administration followed by localized irradiation resulted in an 80% reduction in tumor volume after 10 days, with no observed systemic toxicity or off-target effects. These findings demonstrate that Ru(tpy)2TT circumvents hypoxia-induced PDT resistance in melanoma via hypoxia-tolerant and oxygen-dependent ROS pathways, establishing its potential as a targeted precision antitumor agent. Furthermore, this work provides a generalizable molecular design strategy for developing hypoxia-tolerant PDT agents for refractory melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Molecular Sciences, Henan University, Kaifeng475004, P. R. China.
- School of Basic Medical Science, Henan University, Kaifeng475004, P. R. China.
ORCID-Profile: Weixia Qing, Yong Wang, Pengtao Ma
Förderung
- Henan Provincial Science and Technology Research Project
Zitieren
APA
Li, X., Zhang, Y., Huang, Y., Qing, W., Wang, Y., & Ma, P. (2026). Rationally Designed Ru(II) Complex with Dual Type I/II ROS Generation for Hypoxia-Tolerant Photodynamic Therapy in Melanoma. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.6c04054
Vancouver
Li X, Zhang Y, Huang Y, Qing W, Wang Y, Ma P. Rationally Designed Ru(II) Complex with Dual Type I/II ROS Generation for Hypoxia-Tolerant Photodynamic Therapy in Melanoma. Inorganic Chemistry. 2026. doi:10.1021/acs.inorgchem.6c04054
BibTeX
@article{Li2026,
author = {Li, Xueling and Zhang, Yue and Huang, Yan and Qing, Weixia and Wang, Yong and Ma, Pengtao},
title = {Rationally Designed Ru(II) Complex with Dual Type I/II ROS Generation for Hypoxia-Tolerant Photodynamic Therapy in Melanoma},
journal = {Inorganic Chemistry},
year = {2026},
doi = {10.1021/acs.inorgchem.6c04054}
}
EUVIMED